Home 2025

Archives

A Futuristic 3D Illustration depicting a DNA double helix, in Gold - Metal and Green Color, encapsulated within a transparent Capsule - Medicine. This Modern Conceptual Symbol represents advancements in Healthcare And Medicine, particularly Biotechnology, Genetic Modification, and gene therapy. The Glowing Molecular Structure inside the Pill signifies Innovation in Medical Research and the Hope - Concept for targeted treatments. The Abstract Backgrounds in shades of Blue and purple enhance its Science and Technology aesthetic.

Single-chromosome sequencing and personalised medicine

Discover how personalised medicine uses genomic sequencing, biomarkers, and pharmacogenetics to tailor treatments. Learn about CYP gene alleles, miRNA, and their impact on drug response and precision healthcare.
DNA fingerprints in blue tone.

Single chromosome sequencing with Haplomic Technologies

Explore single chromosome sequencing with Haplomic Technologies, starting with some background and corporate history.
Unrecognizable pharma research scientist selecting the only set of drugs personalized by genome sequencing in a lineup of pills and tablets. Healthcare concept for pharmacogenomics, pharmacogenetics.

CYP genes and haplotypes in personalised medicine

Brian Tait, Chief Scientific Officer at Haplomic Technologies Pty Ltd, focuses here on CYP genes, haplotypes, and their applications in personalised medicine.
Haplomic Technologies Pty Ltd

Haplomic Technologies Pty Ltd

The Company Haplomic Technologies Pty Ltd (HT) was established in 2004 by the late Dr Malcolm Simons and Mr Geoff Swanson with the specific objectives of developing intellectual property for the DNA sequencing of single chromosomes to determine haplotypic phase.
FIGURE 1 shows the basic steps required to obtain genetic phase or haplotyping for the HLA system in a potential bone marrow transplant recipient without resorting to family studies. Studies to date have shown superior outcomes in haplotype-matched recipient/donor pairs compared to those matched for individual alleles at multiple HLA loci. (Kitcharoen, Petersdorf, Maskalana)

Single chromosome sequencing to obtain genetic phase (haplotyping)

Brian Tait, Chief Scientific Officer at Haplomic Technologies Pty Ltd, examines single chromosome sequencing to obtain genetic phase (haplotyping).

Follow Us

Advertisements

Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd